Back to UBS Group AG UBS Group AG

ABEOABEO
Showing 8 of 15 quarters

Position history for UBS Group AGUBS Group AG's holdings in ABEONA THERAPEUTICS INC

UBS Group AG holds 223,279 shares of ABEO (ABEONA THERAPEUTICS INC), worth $1.4M as of 2026-Q2. The position was decreased (-4.5% shares). ABEO represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.4M

Current Shares

223,279

Total Value Change

+$1.4M

Total Shares Change

+223,279

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
223,279
-4.5%
$1.4M0.0%$6.18
0
2026-Q1
Increased
233,924
+45.8%
$1M0.0%$4.94
34
2025-Q4
Increased
160,401
+25.1%
$845,3130.0%$5.18
30
2025-Q3
Increased
128,232
+9.7%
$677,0650.0%$5.33
27
2025-Q2
Increased
116,942
+17.7%
$664,2310.0%$5.75
29
2025-Q1
Increased
99,319
+57.7%
$472,7580.0%$4.97
34
2024-Q4
New
62,997
-
$350,8930.0%$5.61
33
2024-Q3
Exited
0
-100.0%
$00.0%$5.89
0

Other major holders of ABEO: ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used